A Randomized Controlled Trial of a Behavioral Weight Loss Program for Human Immunodeficiency Virus-Infected Patients

被引:16
|
作者
Becofsky, Katie [1 ]
Wing, Edward J. [1 ]
McCaffery, Jeanne [1 ]
Boudreau, Matthew [1 ]
Wing, Rena R. [1 ]
机构
[1] Brown Univ, Miriam Hosp, Alpert Med Sch, Providence, RI USA
关键词
weight loss; adherence; quality of life; HIV; OBESITY; ADULTS; HEALTH;
D O I
10.1093/cid/cix238
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Obesity compounds the negative health effects of human immunodeficiency virus (HIV) infection. We conducted the first randomized trial of behavioral weight loss for HIV-infected patients (n = 40). Participants randomized to an Internet behavioral weight loss program had greater 12-week weight loss (mean, 4.4 +/- 5.4 kg vs 1.0 +/- 3.3 kg; P = .02) and improvements in quality of life than controls.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 50 条
  • [1] Primary care for patients infected with human immunodeficiency virus - A randomized controlled trial
    Keitz, SA
    Box, TL
    Homan, RK
    Bartlett, JA
    Oddone, EZ
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (09) : 573 - 582
  • [2] Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss
    Choi, HH
    Gray, PB
    Storer, TW
    Calof, OM
    Woodhouse, L
    Singh, AB
    Padero, C
    Mac, RP
    Sinha-Hikim, I
    Shen, R
    Dzekov, J
    Dzekov, C
    Kushnir, MM
    Rockwood, AL
    Meikle, AW
    Lee, ML
    Hays, RD
    Bhasin, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1531 - 1541
  • [3] Low molecular weight proteinuria in human immunodeficiency virus-infected patients
    Kabanda, A
    Vandercam, B
    Bernard, A
    Lauwerys, R
    deStrihou, CV
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (06) : 803 - 808
  • [4] Weight loss and wasting in patients infected with human immunodeficiency virus
    Grinspoon, S
    Mulligan, K
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 : S69 - S78
  • [5] Reduced testosterone levels in human immunodeficiency virus-infected women with weight loss and low weight
    Huang, JS
    Wilkie, SJ
    Dolan, S
    Gallafent, JH
    Aliabadi, N
    Sullivan, MP
    Grinspoon, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (04) : 499 - 506
  • [6] Left ventricular mass and systolic function in human immunodeficiency virus-infected patients after weight loss
    Umana, E
    Panayiotou, H
    Ramsey, KA
    Bikkina, M
    Massey, CV
    Alpert, MA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (09): : 1040 - 1043
  • [7] Lipodystrophy in human immunodeficiency virus-infected patients
    Chen, DL
    Misra, A
    Garg, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11): : 4845 - 4856
  • [8] MYALGIAS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    BUSKILA, D
    LANGEVITZ, P
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04): : 510 - 511
  • [9] Hyperhomocysteinemia in human immunodeficiency virus-infected patients
    Duro, M.
    Manso, M. C.
    Rebelo, I
    Medeiros, R.
    Almeida, C.
    [J]. BIOMEDICAL RESEARCH-INDIA, 2016, 27 (02): : 557 - 562
  • [10] Hepatitis A in human immunodeficiency virus-infected patients
    Wallace, MR
    Hill, HE
    Tasker, SA
    Miller, LK
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (03) : 651 - 653